glp-1 tirzepatide vs semaglutide Semaglutide: what's the difference? 👀 Both are game-changers in metabolic medicine — but they don't work exactly the same: ✨ → Mimics only → Reduces appetite → Slows Tirzepatide vs semaglutide which is

GLP-1 functions to delay gastric emptying, stimulate insulin secretion and mediate satiety in the central nervous system (CNS), all actions that are beneficial to individuals with obesity and type 2 diabetes

ne dnda alternatif yok mu

These sources are provided for literature context only and do not change the Nexus research-use-only status of this material

The combination is most useful for patients with one or more of the following: BMI of 30 or higher , or BMI 27 with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea History of fatigue, low mood, or brain fog on previous diets or weight loss attempts Metformin use for type 2 diabetes or pre-diabetes (chronic metformin reduces B12) Long-term proton pump inhibitor use such as omeprazole, pantoprazole, or lansoprazole Vegetarian or vegan diet with limited animal protein intake Adults over 50 , where B12 absorption naturally declines Active strength training or higher physical demands while on a calorie deficit Patients who dont fit any of these profiles can still take semaglutide alone, then add B12 if symptoms suggest it

Only one study looked at those with gastroparesis

These risks may be especially pronounced for people taking GLP-1 drugs to treat type 1 diabetes, a group that has grown considerably over the last decade despite a lack of evidence for the compounds safety or efficacy among this cohort